Dr. Geoffrey Y. Ku
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Gastroesophageal Junction Adenocarcinoma
Studies Esophageal Cancer
9 reported clinical trials
23 drugs studied
Area of expertise
1Gastroesophageal Junction Adenocarcinoma
Stage IV
HER2 positive
Stage III
2Esophageal Cancer
Stage IV
HER2 positive
Stage I
Affiliated Hospitals
Clinical Trials Geoffrey Y. Ku is currently running
CAR T-Cell Therapy
for Esophageal Cancer
Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory at Memorial Sloan Kettering to be changed (modified) to become MSLN-targeted CAR T cells, the CAR T-cell therapy that participants will receive during the study. Participant study therapy will take about 3-4 weeks.
Recruiting1 award Phase 19 criteria
TAC01-CLDN18.2 Engineered T-cells
for Cancer
TAC01-CLDN18.2 is a novel cell therapy that consists of genetically engineered autologous T cells expressing T-cell Antigen Coupler (TAC) that recognizes Claudin 18.2. TAC directs T-cells to the targeted antigen (CLDN 18.2), and once engaged with the target, activates them via the endogenous T cell receptor. This is an open-label, multicenter Phase ½ study that aims to establish safety, maximum tolerated dose (MTD) or recommended Phase 2 dose (RP2D), pharmacokinetic profile and efficacy of TAC01-CLDN18.2.
Recruiting1 award Phase 1 & 2
More about Geoffrey Y. Ku
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Geoffrey Y. Ku has experience with
- Paclitaxel
- Carboplatin
- M28z1XXPD1DNR CAR
- Durvalumab
- External Beam Radiation (EBRT)
- Tremelimumab
Breakdown of trials Geoffrey Y. Ku has run
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Esophageal Neoplasms
Stomach Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Geoffrey Y. Ku specialize in?
Geoffrey Y. Ku focuses on Gastroesophageal Junction Adenocarcinoma and Esophageal Cancer. In particular, much of their work with Gastroesophageal Junction Adenocarcinoma has involved Stage IV patients, or patients who are HER2 positive.
Is Geoffrey Y. Ku currently recruiting for clinical trials?
Yes, Geoffrey Y. Ku is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Geoffrey Y. Ku has studied deeply?
Yes, Geoffrey Y. Ku has studied treatments such as Paclitaxel, Carboplatin, M28z1XXPD1DNR CAR.
What is the best way to schedule an appointment with Geoffrey Y. Ku?
Apply for one of the trials that Geoffrey Y. Ku is conducting.
What is the office address of Geoffrey Y. Ku?
The office of Geoffrey Y. Ku is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.